Response Pharmaceuticals
Response Pharmaceuticals: A McLean, Virginia-based medical organization specializing in biotechnology.
Founded
2021Response Pharmaceuticals: A McLean, Virginia-based medical organization specializing in biotechnology.
Founded in McLean, Virginia, Response Pharmaceuticals is a biotechnology and pharmaceutical company dedicated to developing targeted solutions for weight management and metabolic health. The company's core mission is to address significant unmet medical needs through innovative drug development, with a vision to improve the quality of life for patients suffering from metabolic disorders. Their primary product focus includes a drug candidate aimed at treating antipsychotic-induced weight gain (AIWG), which has shown promising results in early clinical trials.
Notable figures associated with Response Pharmaceuticals include leading scientists and industry experts in biotechnology. The company has successfully completed a Phase 1B clinical trial for its AIWG treatment, achieving its primary endpoint, which marks a significant milestone in its development pipeline. Additionally, Response Pharmaceuticals secured Series A financing, underscoring investor confidence in their innovative approach. The company’s advancements have the potential to make a substantial impact on the treatment of metabolic health issues, offering new hope to patients and healthcare providers.
Companies similar to Response Pharmaceuticals include Reset Pharmaceuticals, PleoPharma, RS BioTherapeutics and Novita Pharmaceuticals.
Response Pharmaceuticals was founded in 2021.
Response Pharmaceuticals' headquarters is located in McLean, VA, US.
Response Pharmaceuticals' most recent funding round was for $8M (USD) in February 2022.
As of Feb 23, 2022, Response Pharmaceuticals has raised a total of $8M (USD).
Response Pharmaceuticals has 6 employees as of Feb 5, 2024.
RS BioTherapeutics
